CJC / IPA Blend
Growth Hormone Secretagogue - CJC-1295 + Ipamorelin co-formulated GH-research blend.
A co-formulated blend pairing a GHRH analog with a selective secretagogue, prepared for researchers studying the two mechanisms in combination.
This blend exists because GHRH analogs and ghrelin-receptor secretagogues act through complementary mechanisms, and researchers frequently study them together to look at combined GH release. Co-formulation keeps the ratio fixed across a study.
CJC / IPA Blend specifications
- Sequence
- CJC-1295 + Ipamorelin
- Presentation
- Lyophilised powder
- Documented purity
- 99.97% by HPLC
- Available sizes
- 10mg ($100)
- Archived COA lots
- 3
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Dual GH stimulation - Studied for combined GHRH and ghrelin-receptor activity on GH release.
Reported mechanisms in the literature
- Dual GH stimulation - Pairs a GHRH analog with a selective secretagogue, studied for combined GHRH- and ghrelin-receptor activity on GH release. (Combination research)
CJC / IPA Blend frequently asked questions
What is the CJC / IPA blend?
A co-formulation pairing CJC-1295 (a GHRH analog) with Ipamorelin (a selective secretagogue), for researchers studying the two GH mechanisms together.
Is it approved for human use?
No. Neither component is approved for human use; the blend is a research material only.
How is it documented?
The vial ships with a Certificate of Analysis for the combined lot.
Documented to 99.97% purity by HPLC · third-party COA every lot · from $100 · For laboratory research use only.
Related Growth Hormone compounds
- Tesamorelin - GHRH analog studied for growth-hormone-axis research.
- Ipamorelin - Selective GH secretagogue studied for receptor-selective GH release.
- CJC-1295 - GHRH analog studied for sustained GH signalling.